Prevalence of Hyperkalemia in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease: A Nested Case-Control Study

被引:33
|
作者
Loutradis, Charalampos [1 ]
Tolika, Panagiota [2 ]
Skodra, Alexandra [2 ]
Avdelidou, Afroditi [2 ]
Sarafidis, Pantelis A. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Nephrol, Konstantinoupoleos 49, GR-54642 Thessaloniki, Greece
[2] Gen Hosp Grevena, Hemodialysis Unit, Grevena, Greece
关键词
Hyperkalemia; Diabetes; Chronic kidney disease; Angiotensin-converting enzyme inhibitors; GLOMERULAR-FILTRATION-RATE; POTASSIUM; HYPERTENSION; PREDICTORS; MELLITUS; BLOCKADE;
D O I
10.1159/000442393
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Hyperkalemia is a potentially life-threatening disorder, usually complicating chronic kidney disease (CKD). Factors superimposed to reduced renal function are further elevating hyperkalemia risk, but their contribution is not fully elucidated. This study aimed to compare the prevalence of hyperkalemia in diabetic and non-diabetic patients with CKD. Methods: This is a nested case-control study of 180 type-2 diabetic and 180 non-diabetic patients with CKD followed in a Nephrology outpatient clinic, matched for gender, age and estimated glomerular filtration rate. Type-1 diabetes or end-stage renal disease patients were excluded. Prevalence of hyperkalemia was defined as potassium >5 mEq/l or use of sodium polystyrene sulfonate, and further by potassium >5, >= 5.2 and >= 5.5 mEq/1. It was calculated in both groups in whole and CKD stages separately. Univariate and multivariate logistic regression analysis were conducted to identify factors associated with hyperkalemia. Results: The prevalence of hyperkalemia was higher in diabetic CKD patients (27.2 vs. 20%, p = 0.107) and remained around 30% higher with all secondary definitions used, but never reached statistical significance. In Stage 2, no difference was noted (8.7 vs. 17.4%, p = 0.665); in Stage 3, it was significantly higher in diabetics (28.6 vs. 17.5%, p = 0.036); and in Stage 4, it was equally high in both groups (35.5 vs. 32.3%, p = 0.788). In multivariate analysis, Stage 4 CKD (OR 4.535, 95% CI 1.561-13.173), use of angiotensin-converting enzyme inhibitors (ACEls; OR 2.228, 95% CI 1.254-3.958) and smoking (OR 2.254, 95% CI 1.218-4.171) were independently associated with hyperkalemia. Conclusions: Diabetes mellitus was found to elevate the prevalence of hyperkalemia only in CKD Stage 3 patients (moderately impaired renal function). Advanced CKD at Stage 4 and ACEIs are major determinants of hyperkalemia occurrence. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:351 / 360
页数:10
相关论文
共 50 条
  • [41] Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease
    Neuen, Brendon L.
    Yeung, Emily K.
    Rangaswami, Janani
    Vaduganathan, Muthiah
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 : i59 - i69
  • [42] What is the prevalence of chronic kidney disease among hypertensive non-diabetic Egyptian patients attending primary healthcare?
    Nagib, Silvana Nader
    Abdelwahab, Saeed
    Amin, Ghada Essam El-Din
    Allam, Mohamed Farouk
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2023, 45 (01)
  • [43] The Prevalence of Erectile Dysfunction in Type 2 Diabetic and Non-Diabetic Men : A Comparative case control study
    Al-Ghareeb, Huda
    Al-Assoomi, Fatma
    Alresheedy, Fatel
    Srour, Khaled
    Al-Baba, Essam
    Othman, Saif
    Al-Yooha, Sara Ali
    Al-Yooha, Noora Ali
    WORLD FAMILY MEDICINE, 2011, 9 (04): : 11 - 16
  • [44] PREVALENCE AND OUTCOMES OF NON-DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETES MELLITUS PATIENTS
    Prasad, Narayan
    Bhadauria, Dharmender
    Gupta, Anurag
    Sharma, Raj Kumar
    Gupta, Amit
    Kaul, Anupama
    Jain, Manoj
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 171 - 172
  • [45] Hemodynamic parameters in diabetic and non-diabetic subjects; a case control study
    Topsever, P
    Filiz, MT
    Salman, S
    Aydin, N
    DIABETOLOGIA, 2003, 46 : A348 - A348
  • [46] PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A CASE-CONTROL STUDY
    Adrian, Therese
    Hornum, Mads
    Soerensen, Ida Maria Hjelm
    Ballegaard, Ellen Linnea Freese
    Bro, Susanne
    Kuhl, Joergen Tobias
    Sigvardsen, Per Ejlstrup
    Fuchs, Andreas
    Kofoed, Klaus F.
    Knop, Filip K.
    Feldt-Rasmussen, Bo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [47] The Characteristics of Blood Pressure Variability in Subjects with Chronic Kidney Disease Stage III in Diabetic or Non-diabetic Patients
    Aleksandrovna, Klitsunova Yuliia
    Alekseevich, Ostapenko Andrii
    Timofeevna, Ivahnenko Nataliia
    Sergeevich, Kulbachuk Aleksandr
    Aleksandrovna, Ivaschuk Viktoriia
    ASIAN JOURNAL OF PHARMACEUTICS, 2018, 12 (01) : S309 - S313
  • [48] Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients
    Takahashi, Nobuyuki
    Morimoto, Satoshi
    Okigaki, Mitsuhiko
    Seo, Maiko
    Someya, Kazunori
    Morita, Tatsuyori
    Matsubara, Hiroaki
    Sugiura, Tetsuro
    Iwasaka, Toshiji
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (04) : 1252 - 1257
  • [49] When to Suspect Non-diabetic Kidney Disease in a Diabetic Patient?
    John, Elenjickal Elias
    Roy, Sanjeet
    Eapen, Jeethu Joseph
    Alam, Rizwan
    Varughese, Santosh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [50] Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography
    Maha Abdelmoneim Behairy
    Ahmed Fouad Sherief
    Hany Aly Hussein
    International Urology and Nephrology, 2021, 53 : 2593 - 2601